article thumbnail

Gilead Presents Data Demonstrating Established, Investigational HIV Drugs

Drug Topics

Among the drugs presented, Biktarvy and lenacapavir, teropavimab, and zinlirvimab (LTZ) demonstrate rates of suppression of HIV, and vesatolimod is well tolerated.

416
416
article thumbnail

Medication Dosing in Pediatric Obesity Presents Complexities and Challenges

Drug Topics

Careful thought and adjustments are required to avoid exceeding the maximum recommended amount.

469
469
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chronic Hand Eczema Studies Show Condition is Common, Burdensome

Drug Topics

LEO Pharma presented data from 2 of the largest multinational real-world studies on the prevalence, severity and treatment of chronic hand eczema at the European Society of Contact Dermatitis congress.

586
586
article thumbnail

Over 300 Pharmacy Closures Reported in the Last 3 Months

Drug Topics

A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress failure to pass PBM reform at the end of 2024.

574
574
article thumbnail

What States are Doing to Regulate Pharmacy Benefit Managers

Drug Topics

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers assessed state-level regulations for PBMs.

618
618
article thumbnail

Takeda presents positive results from trial of chronic kidney disease treatment

Pharmafile

The data was presented at the European Renal Association Congress on 6 June 2025 […] The post Takeda presents positive results from trial of chronic kidney disease treatment appeared first on Pharmafile. The Japanese biopharma is now looking ahead to a prospective phase 3 trial of mezagitamab.

80
article thumbnail

Continuous Glucose Monitors Help Reduce A1c in Patients with Diabetes

Drug Topics

Research presented at the American Diabetes Association 84th Scientific Sessions suggests a population approach to CGM use could be beneficial.

530
530